Lilly to invest additional US$ 5.3 bn to boost obesity drug supply; FDA panel votes against Novo’s weekly insulin
This week’s Phispers comes packed with news of investments, acquisitions, deals and trials. Eli Lilly has more than doubl...
Impressions : 1621

